Moderna Inc (NASDAQ:MRNA)
| 173.91 Delayed Data As of 5:15pm ET |  -12.70 / -6.81%Today’s Change | 117.34 Today|||52-Week Range 497.49 | -31.53% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 186.61 |
| Today’s open | 188.53 |
| Day’s range | 172.53 - 191.27 |
| Volume | 460,049 |
| Average volume (3 months) | 12,360,251 |
| Market cap | $83.0B |
Data as of 5:15pm ET, 01/19/2022
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,460.00% |
| Earnings growth (next 5 years) | -21.63% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | 10.7 |
| Price/Sales | 49.59 |
| Price/Book | 31.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -1.34 | -1.90% |
| ILMNIllumina Inc | +1.15 | +0.30% |
| BIIBBiogen | -2.93 | -1.25% |
| ---- |
Data as of 5:03pm ET, 01/19/2022
Financials
| Next reporting date | March 9, 2022 |
| EPS forecast (this quarter) | $9.14 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
